Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vikse, B. E.
Right arrow Articles by Iversen, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vikse, B. E.
Right arrow Articles by Iversen, B. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1603-1613
© 2002 European Renal Association-European Dialysis and Transplant Association

Prognostic factors in mesangioproliferative glomerulonephritis

Bjørn Egil Vikse1,, Leif Bostad2, Knut Aasarød3, Dag Einar Lysebo1 and Bjarne M. Iversen1

The Norwegian Kidney Register, 1 Institute of Medicine and 2 Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen and 3 Department of Medicine, University Hospital of Trondheim, Trondheim, Norway

Background. The aim of our study was to examine patients with mesangioproliferative glomerulonephritis (MPGN), with or without glomerular IgA deposits, and to analyse the effect of different clinical and histopathological variables at the time of biopsy on progression to end-stage renal failure (ESRF) and death.

Methods. We retrospectively examined 273 patients who got this diagnosis in Norway from April 1988 to December 1990 after a renal biopsy. All patients were followed for a median duration of 34.8 months (0.8–68 months).

Results. The mean age at the time of biopsy was 40±17 years (range 1.1–79 years). Glomerular IgA deposits were present in 45% of the patients; IgA deposits did not affect prognosis. Three years after the time of biopsy, 7% had developed ESRF (chronic dialysis treatment or kidney transplantation) and 8% had died. By Kaplan–Meier analyses, the following clinical variables indicated progression to ESRF: increased serum creatinine, proteinuria >=1 g/24 h, systolic blood pressure (BP) >=160 mmHg, diastolic BP >=90 mmHg, serum albumin <35 g/l, presence of urinary granular casts and age >=60 years. Morphological variables indicating progression to ESRF were presence of focal mesangial sclerosis, focal glomerular crescents or necroses, benign nephrosclerosis and increased interstitial score. In the multivariable analysis, the following variables indicated progression to ESRF: increased serum creatinine (P<0.001), decreased serum albumin (P<0.05), increased diastolic BP (P<0.05), low age (P<0.05) and increased interstitial score (P<0.001).

Conclusions. It is possible from clinical and histopathological variables to identify low-risk and high-risk patients at the time of biopsy. There is, however, considerable convergence. A major new observation is the finding of young age, decreased serum albumin and the presence of urinary granular casts as important clinical risk factors. Interstitial damage was the most important histopathological predictor of ESRF.

Keywords: clinical risk factors; end-stage renal failure; histopathological risk factors; IgA nephropathy; mesangioproliferative glomerulonephritis

Correspondence and offprint requests to: Bjørn Egil Vikse, Jørgen Moes gt 20, N-5053 Bergen, Norway. Email: bjorn.vikse{at}student.uib.no


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
G. S Braun, S. Horster, K. S Wagner, S. Ihrler, and H. Schmid
Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects
Postgrad. Med. J., February 1, 2007; 83(976): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Wakai, T. Kawamura, M. Endoh, M. Kojima, Y. Tomino, A. Tamakoshi, Y. Ohno, Y. Inaba, and H. Sakai
A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2800 - 2808.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.